Trial Profile
Duloxetine for the Treatment of Dysthymia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2009
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Dysthymic disorder
- Focus Therapeutic Use
- 14 Apr 2009 Actual end date (Apr 2006) added as reported by ClinicalTrials.gov.
- 14 Apr 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 Apr 2009 Planned end date changed from 1 Apr 2006 to 1 Dec 2006 as reported by ClinicalTrials.gov.